Literature DB >> 2471650

Timing of appearance and disappearance of IFN and IL-2 induced natural immunity during ontogenetic development and aging.

M Provinciali1, M Muzzioli, N Fabris.   

Abstract

The age-dependent modifications of both basal and lymphokine-induced natural killer (NK) activity were analyzed in Balb/c inbred mice by measuring either the percentage of specific lytic activity in a 51 Cr release assay or the percentage of cells capable of binding the YAC-1 target cells. The basal lytic activity of spleen cells is low at birth, then it increases progressively and reaches a peak between 5 and 8 weeks of age and decreases thereafter, displaying in 25-month-old mice only 10% of the NK activity found in young mice. The number of spleen cells capable of binding target cells is higher at birth and then it declines progressively-old mice show about 40% of the binding capacity found in young mice. Significant in vitro NK activation is obtained in spleen cells from 25-, 50- and 750-day-old mice by incubation with interleukin-2 (IL-2) (1.8-fold increase in 25- and 50-day-old mice and 2.6-fold increase in 750-day-old mice) while no effect is obtained in 15-day-old mice. The responsiveness to in vitro stimulation with interferon (IFN) is not present in 15-day-old mice, however it appears in a defective way at the age of 25 days, and reaches its highest level in 50- and 180-day-old mice, (3.5- and 4.5-fold increase), still remaining present in 630-day-old mice, (two-fold increase) but not in 750-day-old mice. The in vivo injection with IFN increases the spleen cell NK activity of 25- and 50-day-old mice (3.6- and 2.3-fold increase respectively) but not of 15- and 750-day-old mice. The present data here confirm the existence of age-dependent variations of spleen cell NK activity and suggest a similar sequential timing of appearance/disappearance of IL-2 and IFN responsive spleen cells during ontogenetic development and aging respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471650     DOI: 10.1016/0531-5565(89)90014-4

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  8 in total

1.  Age-related Dysregulation of Inflammation and Innate Immunity: Lessons Learned from Rodent Models.

Authors:  Aleah L Brubaker; Jessica L Palmer; Elizabeth J Kovacs
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

2.  Sequential activation of hormone/cytokines in the stimulation of NK cells: A new model of neuroendocrine-immune interaction.

Authors:  M Provinciali; N Fabris
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

3.  Differential effects of stimulatory factors on natural killer cell activities of young and aged mice.

Authors:  Shoko Nogusa; Donna M Murasko; Elizabeth M Gardner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-27       Impact factor: 6.053

4.  Modulation of lymphoid cell sensitivity to interferon by thyroid hormones.

Authors:  M Provinciali; N Fabris
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

5.  Dysfunction of dendritic cells in aged C57BL/6 mice leads to failure of natural killer cell activation and of tumor eradication.

Authors:  Zhenhong Guo; Tamara Tilburgs; Bonnie Wong; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-15       Impact factor: 11.205

6.  The host environment is responsible for aging-related functional NK cell deficiency.

Authors:  Bo-Chin Chiu; Brian E Martin; Valerie R Stolberg; Stephen W Chensue
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

Review 7.  NK and NKT cells in aging and longevity: role of zinc and metallothioneins.

Authors:  Eugenio Mocchegiani; Robertina Giacconi; Catia Cipriano; Marco Malavolta
Journal:  J Clin Immunol       Date:  2009-05-01       Impact factor: 8.317

8.  Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.

Authors:  K Geiger; E L Howes; N Sarvetnick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.